← Back to All Filings
Merck & Co. Director Mary Ellen Coe Acquires Phantom Stock Units
Merck & Co., Inc.
$MRK4CIK: 0000310158
Subscribe to track MRK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
### Insider Transaction Alert
**Issuer:** Merck & Co., Inc. (MRK)
**Insider:** Mary Ellen Coe (Director)
**Transaction:** Acquisition (Award) of 206.46 Phantom Stock units at $145.31 per share (~$30,000 total value)
**Date:** 2026-09-30
**Post-Transaction Holdings:** 32,419.87 Phantom Stock units
**Significance:** Low (Routine Director Compensation Deferral)
Comprehensive Analysis
Analysis of Form 4 Filing for Merck & Co., Inc. (MRK)
Overview
On October 1, 2026, Merck & Co., Inc. filed a Form 4 on behalf of Director Mary Ellen Coe, reporting a derivative transaction executed on September 30, 2026.
Transaction Details
- Security: Phantom Stock
- Transaction Code:
A(Grant, award, or other acquisition) - Shares Acquired: 206.4552 units
- Price per Share: $145.31
- Total Value: Approximately $30,000.01
- Ownership Nature: Direct
- Post-Transaction Beneficial Ownership: 32,419.8658 phantom stock units (also holds 10 direct shares of Common Stock)
Context and Significance
- Nature of the Transaction: The acquisition represents an allocation under the Plan for Deferred Payment of Directors' Compensation. The phantom stock units convert on a 1-for-1 basis into cash upon the director's termination of service according to their deferred election schedule.
- Significance: Low. This transaction is part of standard, scheduled board compensation deferrals and does not reflect an open-market purchase or sale.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.